Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ken Fujioka

Showing results (51-60 of 64) with videos related to

Pageof 7
Sort By:
The New England Journal of Medicine|July 2, 2015
A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight ManagementXavier Pi-Sunyer, Arne Astrup, Ken Fujioka, et al.
Lancet (London, England)|February 27, 2017
3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trialCarel W le Roux, Arne Astrup, Ken Fujioka, et al.
Obesity (Silver Spring, Md.)|April 10, 2010
A randomized trial of lifestyle modification and taranabant for maintaining weight loss achieved with a low-calorie dietThomas A Wadden, Ken Fujioka, Soren Toubro, et al.
JPEN. Journal of Parenteral and Enteral Nutrition|November 23, 2016
Independence From Parenteral Nutrition and Intravenous Fluid Support During Treatment With Teduglutide Among Patients With Intestinal Failure Associated With Short Bowel SyndromeKishore R Iyer, Marek Kunecki, Joseph I Boullata, et al.
Annals of Internal Medicine|July 19, 2006
Effects of sibutramine treatment in obese adolescents: a randomized trialRobert I Berkowitz, Ken Fujioka, Stephen R Daniels, et al.
Obesity (Silver Spring, Md.)|November 11, 2008
Rational design of a combination medication for the treatment of obesityFrank L Greenway, M J Whitehouse, Maria Guttadauria, et al.
JPEN. Journal of Parenteral and Enteral Nutrition|September 2, 2011
Nutrition therapy of the severely obese, critically ill patient: summation of conclusions and recommendationsStephen A McClave, Robert Kushner, Charles W Van Way, et al.
Obesity (Silver Spring, Md.)|November 3, 2016
Randomized controlled trial of a nationally available weight control program tailored for adults with type 2 diabetesPatrick M O'Neil, Karen Miller-Kovach, Peter W Tuerk, et al.
International Journal of Obesity (2005)|January 18, 2020
Changes in weight control behaviors and hedonic hunger in a commercial weight management program adapted for individuals with type 2 diabetesErica M Schulte, Peter W Tuerk, Thomas A Wadden, et al.
Obesity Surgery|September 8, 2012
The EMPOWER study: randomized, prospective, double-blind, multicenter trial of vagal blockade to induce weight loss in morbid obesityMichael G Sarr, Charles J Billington, Roy Brancatisano, et al.
Pageof 7

Showing results (51-60 of 64) with videos related to

Sort By:
Pageof 7
The New England Journal of Medicine|July 2, 2015
A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight ManagementXavier Pi-Sunyer, Arne Astrup, Ken Fujioka, et al.
Lancet (London, England)|February 27, 2017
3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trialCarel W le Roux, Arne Astrup, Ken Fujioka, et al.
Obesity (Silver Spring, Md.)|April 10, 2010
A randomized trial of lifestyle modification and taranabant for maintaining weight loss achieved with a low-calorie dietThomas A Wadden, Ken Fujioka, Soren Toubro, et al.
JPEN. Journal of Parenteral and Enteral Nutrition|November 23, 2016
Independence From Parenteral Nutrition and Intravenous Fluid Support During Treatment With Teduglutide Among Patients With Intestinal Failure Associated With Short Bowel SyndromeKishore R Iyer, Marek Kunecki, Joseph I Boullata, et al.
Annals of Internal Medicine|July 19, 2006
Effects of sibutramine treatment in obese adolescents: a randomized trialRobert I Berkowitz, Ken Fujioka, Stephen R Daniels, et al.
Obesity (Silver Spring, Md.)|November 11, 2008
Rational design of a combination medication for the treatment of obesityFrank L Greenway, M J Whitehouse, Maria Guttadauria, et al.
JPEN. Journal of Parenteral and Enteral Nutrition|September 2, 2011
Nutrition therapy of the severely obese, critically ill patient: summation of conclusions and recommendationsStephen A McClave, Robert Kushner, Charles W Van Way, et al.
Obesity (Silver Spring, Md.)|November 3, 2016
Randomized controlled trial of a nationally available weight control program tailored for adults with type 2 diabetesPatrick M O'Neil, Karen Miller-Kovach, Peter W Tuerk, et al.
International Journal of Obesity (2005)|January 18, 2020
Changes in weight control behaviors and hedonic hunger in a commercial weight management program adapted for individuals with type 2 diabetesErica M Schulte, Peter W Tuerk, Thomas A Wadden, et al.
Obesity Surgery|September 8, 2012
The EMPOWER study: randomized, prospective, double-blind, multicenter trial of vagal blockade to induce weight loss in morbid obesityMichael G Sarr, Charles J Billington, Roy Brancatisano, et al.
Pageof 7